Search
for

    Sort by

    Research 91–120 of 1000+

    1. A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection The Milbank Quarterly · 2006 · 108 citations
    2. Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women Current Dermatology Reports · 2013 · 7 citations
    3. Ritlecitinib in severe alopecia areata: a profile of its use Drugs & Therapy Perspectives · 2024
    4. A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system Scientific Reports · 2025 · 2 citations
    5. Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist Expert opinion on pharmacotherapy · 2021 · 9 citations
    6. Endocrine disorders and hormonal therapy for adolescent acne Current Opinion in Pediatrics · 2017 · 5 citations
    7. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026
    8. A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov Medicina · 2023 · 3 citations
    9. Clinical Trials and Hair Loss Elsevier eBooks · 2018 · 1 citations
    10. Physiology and Medical Treatments for Alopecia Facial Plastic Surgery Clinics of North America · 2020 · 8 citations
    11. Androgenetic Alopecia: Therapy Update Drugs · 2023
    12. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo Journal of The American Academy of Dermatology · 2019 · 25 citations
    13. Exploring novel management options for alopecia areata The American Journal of Managed Care · 2026
    14. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms JEADV Clinical Practice · 2022 · 1 citations
    15. Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists Dermatology and Therapy · 2025
    16. Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata The Open Dermatology Journal · 2023
    17. Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis JMIR Dermatology · 2026
    18. Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases Frontiers in Pharmacology · 2024 · 25 citations
    19. From Eye Care to Hair Growth: Bimatoprost Pharmaceuticals · 2024
    20. The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report JAAD Case Reports · 2024 · 6 citations
    21. Alopecia: A review of laser and light therapies Dermatology Online Journal · 2012 · 40 citations
    22. Biologics in the management of childhood atopic dermatitis 2023 · 4 citations
    23. Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment Annals of palliative medicine · 2019 · 7 citations
    24. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors Journal of autoimmunity · 2022 · 6 citations
    25. Male Androgenetic Alopecia — Endotext 2000
    26. Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement Australasian Journal of Dermatology · 2025
    27. How to treat androgenetic alopecia – the most common form of hair loss. A review Journal of Education, Health and Sport · 2024
    28. Lipolytic agents for submental fat reduction: Review Skin research and technology · 2024 · 1 citations
    29. Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review Journal of Education Health and Sport · 2025
    30. Managing patterned hair loss – a hair raising task! Cosmoderma · 2021